Trials / Unknown
UnknownNCT05056467
Labor Induction in Preeclampsia High-risk Women
Labor Induction Versus Expectant Management in High-risk Women for Preeclampsia
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 825 (estimated)
- Sponsor
- Chinese University of Hong Kong · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Preeclampsia (PE) is one of the leading causes of maternal and perinatal morbidity and mortality. This pregnancy-specific disorder poses to both pregnant women and their offspring an increased risk of immediate and long-term health problems. The study team is conducting a study entitled "FORECAST" (Implementation of First-trimester Screening and preventiOn of pREeClAmpSia Trial) and established the infrastructure for the first-trimester "screen and prevent" program for preterm PE. However, there is no established evidence regarding the benefit of scheduled labor induction versus expectant management among women identified as high-risk for PE with uncomplicated pregnancy at term. The investigators postulate that induction of labor at 39 weeks' gestation may possibly be an effective intervention to reduce placental complications in women with uncomplicated pregnancy by 39 weeks at high-risk PE women.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Induction of Labor | Induction of Labor at 39 weeks of gestation |
Timeline
- Start date
- 2022-01-01
- Primary completion
- 2024-08-30
- Completion
- 2024-12-31
- First posted
- 2021-09-24
- Last updated
- 2023-05-19
Locations
8 sites across 7 countries: China, Hong Kong, Indonesia, Singapore, Taiwan, Thailand, Vietnam
Source: ClinicalTrials.gov record NCT05056467. Inclusion in this directory is not an endorsement.